共查询到20条相似文献,搜索用时 15 毫秒
1.
2.
3.
4.
5.
6.
7.
8.
Response evaluation criteria for solid tumours in dogs (v1.0): a Veterinary Cooperative Oncology Group (VCOG) consensus document 下载免费PDF全文
S. M. Nguyen D. H. Thamm D. M. Vail C. A. London 《Veterinary and comparative oncology》2015,13(3):176-183
In veterinary medical oncology, there is currently no standardized protocol for assessing response to therapy in solid tumours. The lack of such a formalized guideline makes it challenging to critically compare outcome measures across various treatment protocols. The Veterinary Cooperative Oncology Group (VCOG) membership consensus document presented here is based on the recommendations of a subcommittee of American College of Veterinary Internal Medicine (ACVIM) board‐certified veterinary oncologists. This consensus paper has used the human response evaluation criteria in solid tumours (RECIST v1.1) as a framework to establish standard procedures for response assessment in canine solid tumours that is meant to be easy to use, repeatable and applicable across a variety of clinical trial structures in veterinary oncology. It is hoped that this new canine RECIST (cRECIST v1.0) will be adopted within the veterinary oncology community and thereby facilitate the comparison of current and future treatment protocols used for companion animals with cancer. 相似文献
9.
10.
11.
12.
13.
14.
K.R. Muñana D. Zhang E.E. Patterson 《Journal of veterinary internal medicine / American College of Veterinary Internal Medicine》2010,24(1):166-170
Background: The placebo effect is a well-recognized phenomenon in human medicine; in contrast, little information exists on the effect of placebo administration in veterinary patients.
Hypothesis: Nonpharmacologic therapeutic effects play a role in response rates identified in canine epilepsy trials.
Animals: Thirty-four dogs with epilepsy.
Methods: Meta-analysis of the 3 known prospective, placebo-controlled canine epilepsy trials. The number of seizures per week was compiled for each dog throughout their participation in the trial. Log-linear models were developed to evaluate seizure frequency during treatment and placebo relative to baseline.
Results: Twenty-two of 28 (79%) dogs in the study that received placebo demonstrated a decrease in seizure frequency compared with baseline, and 8 (29%) could be considered responders, with a 50% or greater reduction in seizures. For the 3 trials evaluated, the average reduction in seizures during placebo administration relative to baseline was 26% ( P = .0018), 29% ( P = .17), and 46% ( P = .01).
Conclusions and Clinical Importance: A positive response to placebo administration, manifesting as a decrease in seizure frequency, can be observed in epileptic dogs. This is of importance when evaluating open label studies in dogs that aim to assess efficacy of antiepileptic drugs, as the reported results might be overstated. Findings from this study highlight the need for more placebo-controlled trials in veterinary medicine. 相似文献
Hypothesis: Nonpharmacologic therapeutic effects play a role in response rates identified in canine epilepsy trials.
Animals: Thirty-four dogs with epilepsy.
Methods: Meta-analysis of the 3 known prospective, placebo-controlled canine epilepsy trials. The number of seizures per week was compiled for each dog throughout their participation in the trial. Log-linear models were developed to evaluate seizure frequency during treatment and placebo relative to baseline.
Results: Twenty-two of 28 (79%) dogs in the study that received placebo demonstrated a decrease in seizure frequency compared with baseline, and 8 (29%) could be considered responders, with a 50% or greater reduction in seizures. For the 3 trials evaluated, the average reduction in seizures during placebo administration relative to baseline was 26% ( P = .0018), 29% ( P = .17), and 46% ( P = .01).
Conclusions and Clinical Importance: A positive response to placebo administration, manifesting as a decrease in seizure frequency, can be observed in epileptic dogs. This is of importance when evaluating open label studies in dogs that aim to assess efficacy of antiepileptic drugs, as the reported results might be overstated. Findings from this study highlight the need for more placebo-controlled trials in veterinary medicine. 相似文献
15.
16.
利用一种微生态保健品和3种抗菌素药物,即氟哌酸、氯霉素、庆大霉素在兽医临床上用于治疗仔猪黄白痢,断奶猪的应激性腹泻,肥猪及母猪的腹泻作了对比试验,结果表明:微生态保健品对仔猪黄痢的治愈率为93%,对仔猪白痢的治愈率为95%,对断奶仔猪的应激性腹泻治愈率为94%,对肥猪及母猪的腹泻治愈率为100%。与氟哌酸、庆大霉素的疗效比较,差异显著(P<0.05);与氯霉素比较差异极显著(P<0.01). 相似文献
17.
18.
马英 《中国动物传染病学报》2022,(1):190-195
为加强兽药质量评价工作,切实做好兽药临床试验监督检查工作,农业农村部先后颁布《兽药临床研究质量管理规范》(农业部公告第2337号)和《兽药临床试验质量管理规范监督检查标准》及其监督检查相关要求(农业部公告第2464号).农业部第2464号公告[2]规定,自2018年1月1日起,未经我部监督检查或监督检查不合格的兽药安全... 相似文献
19.